Variability of performance status assessment between patients with hematologic malignancies and their physicians.

Leuk Lymphoma 2018 03 18;59(3):695-701. Epub 2017 Jul 18.

c Division of Hematology/Department of Internal Medicine , Mayo Clinic , Rochester , MN , USA.

This study was conducted to determine the incidence of inter-observer variability in Eastern Cooperative Oncology Group (ECOG) performance status (PS) rating between patients with leukemia and lymphoma and their physicians. ECOG PS was assessed at diagnosis by patients and their physicians and stratified by disease subtype, gender, age, disease stage and education. Association between patient- and physician-rated PS and overall survival (OS) was stratified by subtype and prognostic risk score. Overall, 65% of patients and physicians rated PS the same. Age, disease stage and disease subtype were significant predictors of PS disagreement. PS was a significant predictor of OS irrespective of assessment by patients or physicians across all subtypes except those with Hodgkin lymphoma. These findings suggest the need for physicians to better communicate with patients when determining PS, as PS is a strong predictor of survival and is critical in treatment decisions, including determining fitness for cancer treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1347930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901757PMC
March 2018
44 Reads

Publication Analysis

Top Keywords

patients physicians
12
disease subtype
8
performance status
8
age disease
8
disease stage
8
assessment patients
8
physicians
6
patients
6
education association
4
stage education
4
patients determining
4
association patient-
4
survival stratified
4
physician-rated survival
4
patient- physician-rated
4
strong predictor
4
gender age
4
stratified disease
4
disease
4
physicians stratified
4

References

(Supplied by CrossRef)

Similar Publications